Share
Journal Information
Most Often Read
7346
Skin manifestations of liver diseasesA. Koulaouzidis;, S. Bhat;, J. Moschos
Ann Hepatol. 2007;6:181-4
7346
Open access
6241
Shark liver oil: hidden dangersSerta Kilincalp, Murat Deveci, Omer Basar, Fuat Ekiz, Sahin Coban, Osman Yuksel
Ann Hepatol. 2012;11:728-30
6241
Open access
3511
Current concepts in acute liver failureMaximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
3511
Open access
3170
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)Juan P. Arab, Juan P. Roblero, Jose Altamirano, Fernando Bessone, Roberta Chaves Araujo, Fatima Higuera-De la Tijera, Juan Carlos Restrepo, Aldo Torre, Alvaro Urzua, Douglas A. Simonetto, Juan G. Abraldes, Nahum Méndez-Sánchez, Fernando Contreras, Michael R. Lucey, Vijay H. Shah, Helena Cortez-Pinto, Ramon Bataller
Ann Hepatol. 2019;18:518-35
3170
Open access
1518
Report of the Baveno VI Consensus WorkshopAndres Cardenas, Angela Mendez-Bocanegra
Ann Hepatol. 2016;15:289-90
1518
Open access
1401
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosisAurora Loaeza-del-Castillo, Francisco Paz-Pineda, Edgar Oviedo-Cárdenas, Francisco Sánchez-Ávila, Florencia Vargas-Vorácková
Ann Hepatol. 2008;7:350-7
1401
Open access
1391
Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)Sebastião M.B. Duarte, Jose Tadeu Stefano, Claudia P. Oliveira
Ann Hepatol. 2019;18:416-21
1391
Open access
1378
New Insights About Albumin and Liver DiseaseJoana R. Carvalho, Mariana Verdelho Machado
Ann Hepatol. 2018;17:547-60
1378
Open access
1330
Management Strategies for Liver FibrosisAlejandra Altamirano-Barrera, Beatriz Barranco-Fragoso, Nahum Méndez-Sánchez
Ann Hepatol. 2017;16:48-56
1330
Open access
1291
First detection of hepatitis E virus genotype 3 as a common infectious agent in patients with chronic liver damage in MexicoOliver Viera-Segura, Mauricio Realpe-Quintero, Arturo Panduro, Sonia Roman, Alexis Jose-Abrego, Karina Gonzalez-Aldaco, Jorge L. Trujillo-Ochoa, Nora A. Fierro
Ann Hepatol. 2019;18:571-7
1291
Open access
1222
Multiple Biliary Hamartomas, The ‘‘Von Meyenburg Complexes’’Joel O. Jáquez-Quintana, Erick A. Reyes-Cabello, Francisco J. Bosques-Padilla
Ann Hepatol. 2017;16:812-3
1222
Open access
1218
Hepatitis E and chronic liver damage in apparently immunocompetent individuals: Now what?Santiago Mirazo, Juan Arbiza
Ann Hepatol. 2019;18:539-40
1218
Open access
1203
Antioxidants benefits in hepatitis C infection in the new DAAs eraSonia A. Lozano-Sepúlveda, Ana R. Rincón-Sanchez, Ana M. Rivas-Estilla
Ann Hepatol. 2019;18:410-5
1203
Open access
1199
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathyClaudia Isabel Blanco Vela, Jorge Luis Poo Ramírez
Ann Hepatol. 2011;10 Supl 2:S55-9
1199
Open access
1162
Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver DiseasesRuediger S. Goertz, Luise GaBmann, Deike Strobel, Dane Wildner, Barbara Schellhaas, Markus F. Neurath, Lukas Pfeifer
Ann Hepatol. 2019;18:23-9
1162
Open access
1152
Mechanisms of kidney dysfunction in the cirrhotic patient: Non-hepatorenal acute-on-chronic kidney damage considerationsMaría-Jimena Muciño-Bermejo
Ann Hepatol. 2020;19:145-52
1152
Open access
1149
Diagnosis of liver nodules within and outside screening programsMassimo Colombo
Ann Hepatol. 2015;14:304-9
1149
Open access
1134
Fontan-Associated Liver Disease: A ReviewLuis Téllez, Enrique Rodríguez-Santiago, Agustín Albillos
Ann Hepatol. 2018;17:192-204
1134
Open access
1132
Acute-on-chronic liver failure: A comparison of three different diagnostic criteriaGabriel S. Leão, Felipe L. Lunardi, Rafael V. Picon, Cristiane V. Tovo, Angelo A. de Mattos, Ângelo Z. de Mattos
Ann Hepatol. 2019;18:373-8
1132
Open access
Special content about COVID-19
Publish in
Annals of Hepatology
Affiliated societies
